Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BHC

Bausch Health

$23.40

-0.84 (-3.47%)

, OZK

Bank OZK

$41.23

-0.89 (-2.11%)

08:30
07/16/18
07/16
08:30
07/16/18
08:30
Options
Two new option listings and four option delistings on July 16th »

New option listings for…

BHC

Bausch Health

$23.40

-0.84 (-3.47%)

OZK

Bank OZK

$41.23

-0.89 (-2.11%)

HRG

HRG Group

$80.34

-0.72 (-0.89%)

OCIP

OCI Partners

$11.50

(0.00%)

OZRK

Ticker changed to OZK

$0.00

(0.00%)

VRX

Valeant

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 24

    Sep

Saturday
VRX

Valeant

$23.40

-0.84 (-3.47%)

, HLF

Herbalife Nutrition

$53.95

-0.14 (-0.26%)

12:16
07/14/18
07/14
12:16
07/14/18
12:16
Periodicals
Ackman might be making a comeback, Barron's says »

Bill Ackman's…

VRX

Valeant

$23.40

-0.84 (-3.47%)

HLF

Herbalife Nutrition

$53.95

-0.14 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 27

    Aug

Friday
VRX

Valeant

$23.55

-0.69 (-2.85%)

, TEVA

Teva

$23.30

-0.44 (-1.85%)

12:08
07/13/18
07/13
12:08
07/13/18
12:08
Recommendations
Valeant, Teva analyst commentary at Evercore ISI »

Evercore says FDA…

VRX

Valeant

$23.55

-0.69 (-2.85%)

TEVA

Teva

$23.30

-0.44 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 10

    Sep

  • 16

    Sep

XRX

Xerox

$25.16

0.15 (0.60%)

, NWL

Newell Brands

$27.51

0.09 (0.33%)

06:37
07/13/18
07/13
06:37
07/13/18
06:37
Periodicals
Activists launch campaigns at record pace in drive for returns, WSJ says »

Activist investors are…

XRX

Xerox

$25.16

0.15 (0.60%)

NWL

Newell Brands

$27.51

0.09 (0.33%)

GE

General Electric

$13.99

-0.05 (-0.36%)

VRX

Valeant

$24.24

0.48 (2.02%)

PF

Pinnacle Foods

$65.56

-0.3 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

Over a week ago
VRX

Valeant

$22.97

0.035 (0.15%)

08:20
07/09/18
07/09
08:20
07/09/18
08:20
Hot Stocks
Bausch + Lomb: FDA accepts NDA for loteprednol etabonate ophthalmic gel 0.38% »

Bausch + Lomb, a wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

SYN

Synthetic Biologics

$0.22

0.0109 (5.22%)

, VRX

Valeant

$23.60

0.23 (0.98%)

10:44
06/29/18
06/29
10:44
06/29/18
10:44
Hot Stocks
Mizuho says Synthetic Biologics IBS treatment may be 'interesting' for Valeant »

As previously reported,…

SYN

Synthetic Biologics

$0.22

0.0109 (5.22%)

VRX

Valeant

$23.60

0.23 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

VRX

Valeant

$23.37

0.55 (2.41%)

07:36
06/29/18
06/29
07:36
06/29/18
07:36
Recommendations
Valeant analyst commentary at Mizuho »

Valeant price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

VRX

Valeant

$22.82

-0.49 (-2.10%)

07:52
06/28/18
06/28
07:52
06/28/18
07:52
Recommendations
Valeant analyst commentary at Deutsche Bank »

Deutsche reiterates Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

VRX

Valeant

$23.31

0.25 (1.08%)

08:19
06/27/18
06/27
08:19
06/27/18
08:19
Recommendations
Valeant analyst commentary at RBC Capital »

Valeant price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

VRX

Valeant

$23.06

-1.205 (-4.97%)

08:13
06/26/18
06/26
08:13
06/26/18
08:13
Hot Stocks
US WorldMeds and Salix enter into agreement to promote Lucemyra »

US WorldMeds and Salix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.